[Qibai Pingfei囊通过调节基于网络目标和分子动力学模拟的HIF-1α/COX-2通路来改善慢性阻塞性肺病炎的机制]
Qing-Yao Jiang1, Yu-Qi Ye1, Li-Chang-Tian Jiao1
1Anhui University of Chinese Medicine Hefei 230012, China.
概括
奇拜平飞囊通过向HIF-1α/COX-2通路,减少炎症并改善COPD中的肺功能. 这项研究证实了其在止阻塞肺综合征的治疗潜力.
科学领域:
- 综合医学是一个整体医学.
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
背景情况:
- 慢性阻塞性肺病 (COPD) 与静止阻塞性肺综合征呈现复杂的炎症机制.
- 现有的治疗方法在解决COPD病原的多面性方面往往存在局限性.
- 了解所涉及的精确分子点和途径对于开发有效疗法至关重要.
研究的目的:
- 为了阐明Qibai Pingfei囊在COPD中具有静止阻塞肺综合征的抗炎机制.
- 为了确定Qibai Pingfei囊的关键活性成分和分子标.
- 通过体外和体外实验验验证治疗效果和潜在的分子机制.
主要方法:
- 网络药理学以确定核心组件和目标.
- 分子对接和分子动力学模拟以评估结合稳定性.
- 为实验验证建立COPD的老鼠模型,其液静止阻碍肺综合征.
- 评估肺功能,组织学变化,蛋白质表达 (HIF-1α,COX-2) 和炎症因子水平 (TNF-α).
主要成果:
- 网络药理学确定了kaempferol和inosine作为核心成分,以及HIF-1α和COX-2作为关键目标.
- 分子模拟证实了成分与HIF-1α,COX-2和TNF-α的稳定结合.
- 奇拜平飞囊显著改善了肺功能,减少了炎症细胞透,并减轻了COPD大鼠的病理损伤.
- 囊抑制了HIF-1α和COX-2蛋白表达,并降低了TNF-α水平,证实了对HIF-1α/COX-2通路的作用.
结论:
- 奇拜平飞囊通过调节HIF-1α/COX-2信号通路来产生治疗效果.
- 这种机制干预了缺氧应激反应和TNF-α介导的炎症,促进肺组织的修复.
- 这些发现支持Qibai Pingfei囊作为一种潜在的治疗COPD与静止阻塞肺综合征.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719